Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 28 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MAXCYTE, INC. | 13,971,334 | reported | 30 Jul 2021 | tx 1+1,800,000 |
| BIOLIFE SOLUTIONS INC | 7,207,165 | reported | 11 Aug 2025 | tx 4+1,053,350−1,500,000 |
| GeneDx Holdings Corp. | 3,007,164 | reported | 22 Aug 2025 | tx 32+120,455,294−11,583,716 |
| STANDARD BIOTOOLS INC. | 2,954,053 | reported | 26 Feb 2026 | tx 40+32,915,786 |
| Tenaya Therapeutics, Inc. | 39,727 | reported | 10 Jun 2022 | tx 7+3,626,545−2,736,818 |
| Absci Corp | 28,700 | reported | 08 Jun 2022 | tx 8+7,747,293−1,274,431 |
| Century Therapeutics, Inc. | 19,872 | reported | 09 Jun 2022 | tx 5+3,265,996−6,180,500 |
| EXACT SCIENCES CORP | 8,820 | reported | 23 Jul 2020 | tx 6+21,525 |
| 2seventy bio, Inc. | 0 | reported | 13 May 2025 | tx 6+18,075−2,068,075 |
| Generation Bio Co. | 0 | reported | 16 Jun 2020 | tx 4+1,611,215−1,548,910 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 52,991 | 1.17 USD | |
| 20 Nov 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 450,000 | 1.30 USD | |
| 18 Nov 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 275,000 | 1.23 USD | |
| 19 Nov 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 350,000 | 1.28 USD | |
| 04 Sept 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 250,000 | 1.28 USD | |
| 03 Sept 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 250,000 | 1.27 USD | |
| 22 Aug 2025 | SALE | GeneDx Holdings Corp. | 500,000 | 120.90 USD | |
| 13 Aug 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 75,000 | 1.31 USD | first after silence |
| 14 Aug 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 133,220 | 1.21 USD | |
| 15 Aug 2025 | PURCHASE | STANDARD BIOTOOLS INC. | 150,000 | 1.22 USD | |
| 11 Aug 2025 | SALE | BIOLIFE SOLUTIONS INC | 500,000 | 22.60 USD | |
| 20 Jun 2025 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 94,592 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 125,660 | 0.00 USD | deriv |
| 18 Jun 2025 | EXERCISE | GeneDx Holdings Corp. | 12,924 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | GeneDx Holdings Corp. | 3,576 | 0.00 USD | deriv |
| 18 Jun 2025 | EXERCISE | GeneDx Holdings Corp. | 12,924 | 0.00 USD | deriv |
| 10 Jun 2025 | SALE | BIOLIFE SOLUTIONS INC | 1,000,000 | 23.80 USD | |
| 13 May 2025 | TENDER | 2seventy bio, Inc. | 22,625 | 5.00 USD | |
| 13 May 2025 | TENDER | 2seventy bio, Inc. | 2,000,000 | 5.00 USD | |
| 13 May 2025 | OTHER | 2seventy bio, Inc. | 33,400 | — | deriv |
| 13 May 2025 | OTHER | 2seventy bio, Inc. | 12,050 | — | deriv |
| 05 Aug 2024 | PURCHASE | STANDARD BIOTOOLS INC. | 200,000 | 1.58 USD | |
| 02 Aug 2024 | PURCHASE | STANDARD BIOTOOLS INC. | 1,000,000 | 1.63 USD | |
| 19 Jul 2024 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 1,588 | 0.00 USD | |
| 28 Jun 2024 | GRANT_AWARD | STANDARD BIOTOOLS INC. | 43,128 | 0.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 13 Aug 2025.